Appointment booking for Dr. Deborah Schiappa, DO is currently not available.Dr. Deborah Schiappa, DO has not yet fully activated their profile on DiabetesIQ.
Dr. Deborah Schiappa, DO (she/her) is a Infectious Disease Doctor, Internist in Hoffman Estates, IL with over 18 years of experience. What is your opinion of Dr. Deborah Schiappa, DO? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Deborah Schiappa, DO has received over $2,367 which includes payments from the following companies:
$345.56 from Astellas Pharma US Inc
$240.04 from Merck Sharp & Dohme Corporation
$230.55 from Theravance Biopharma Inc.
$228.94 from Janssen Products, LP
$203.14 from Janssen Biotech, Inc.
$200.00 from COMSORT, Inc
$188.50 from Allergan Inc.
$167.28 from Baxalta US Inc
$133.02 from Pfizer Inc.
$65.04 from E.R. Squibb & Sons, L.L.C.
$56.85 from Melinta Therapeutics, Inc.
$42.72 from Theratechnologies Inc.
$40.78 from The Medicines Company
$37.86 from Actavis Pharma Inc
$37.58 from Grifols USA, LLC
$35.39 from Gilead Sciences Inc
$34.61 from Baxter Healthcare
$32.78 from AbbVie, Inc.
$12.65 from Oxford Immunotec Inc.
$12.04 from Bio Products Laboratory, Inc.
Payments received by Dr. Deborah Schiappa, DO were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!